Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

FDA approves Abbott’s Amplatzer Paraclose device for heart valve leaks


Impella registry analyses report lower mortality than CHIP-BCIS3 in high-risk PCI


FDA places Bright Minds’ planned BMB-101 Phase II epilepsy study on partial clinical hold


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Next Frontier in Subvisible Particle Analysis: New Tools and Opportunities

Presented by Danny Chou, President and Founder at Compassion BioSolution, LLC and Mark Bumiller, Technology Manager at Entegris, Inc
21st May 2020


Subvisible Particle Identification & Characterisation by Multi-Technique Methods

Presented by Dr. Jonas Hoeg Thygesen, Novo Nordisk Pharmatech. Followed by Colin Merrifield, ProteinSimple
23rd February 2017


Single Use Manufacturing within the Bristol-Myers Squibb Manufacturing Network – Preparing for Commercial Production

Presented by Lance Marquardt, Associate Director - Upstream Processing for Hopewell Clinical Manufacturing at Bristol-Myers Squibb and  Sara Bell, Senior Marketing Manager for Merck’s single-use product portfolio
17th January 2019


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia